Managers / Q3 2025 · view latest →
Resolute Advisors LLC
CIK 0001800217 · 39 MESA STREET, SUITE 210, SAN FRANCISCO, CA, 94129 · 415-699-0309
Summary
Resolute Advisors LLC reported $389M in U.S.-listed holdings across 75 positions for Q3 2025.
The portfolio is heavily concentrated: U alone accounts for 38.7% of reported value.
Compared with Q2 2025, the fund opened 6 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 49.6% · $193M
- Common Stock · 48.6% · $189M
- ADR · 1.7% · $7M
- Other · 0.2% · $590,562
Quarter-over-Quarter Changes full breakdown →
vs Q2 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Vanguard Internatnl HGH DIV YLD ETF | NEW | +9.7K | 9.7K | +$824,190 | $824,190 |
| BMNRBitmine Immersion Tecnol | NEW | +10.0K | 10.0K | +$519,300 | $519,300 |
| FIGPut Figma Inc | NEW | +5.0K | 5.0K | +$259,350 | $259,350 |
| ETHAiShares Ethereum Trust ETF IV | NEW | +8.0K | 8.0K | +$252,080 | $252,080 |
| UMACUnusual Machs Inc Ne Equ Class Equity | NEW | +10.0K | 10.0K | +$151,000 | $151,000 |
| Aspire Biopharma HLDGS I | NEW | +82.8K | 82.8K | +$17,053 | $17,053 |
| MIGAMicrostrategy Inc Class A | SOLD OUT | −2.5K | 0 | −$1M | $0 |
| 8QRConfluent Inc CMN | SOLD OUT | −8.7K | 0 | −$216,716 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $242M | 90 | May 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $307M | 73 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $389M | 75 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $403M | 72 | Aug 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $347M | 81 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $496M | 91 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $487M | 65 | Nov 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $388M | 57 | Aug 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $541M | 59 | May 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $761M | 73 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $660M | 63 | Nov 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $946M | 65 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $859M | 71 | May 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $764M | 60 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $843M | 141 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $963M | 131 | Aug 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.4B | 132 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $3.3B | 178 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $736M | 526 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $4.0B | 49 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $3.6B | 63 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $5.0B | 133 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.